Kara M. Kelly - Concepedia

Author

Kara M. Kelly

Roswell Park Comprehensive Cancer Center ORCID

Also Known As

Illés, Árpád, K Kelly, K M Kelly, K. Kelly, K. M. Kelly, K.M. Kelly, KARA KELLY, KELLY, K, Kara M. Kelly, Kara Kelly

393

Publications

9.1K

Citations

H-Index

104

Concepts

All Affiliations

Roswell Park Comprehensive Cancer Center Columbia University Irving Medical Center Dana-Farber Cancer Institute Brown University Columbia University

About

Kara M. Kelly is an author at Roswell Park Comprehensive Cancer Center specializing in medicine, oncology, and pediatrics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	31	1.8K
2	Health Sciences	8	8	351
3	Education	4	4	81
4	Public Health	2	2	75
5	Arts	1	1	14

Kara M. Kelly

107

Publications

6.2K

Citations

H-Index

Page 1

	Year	Citations
Long-term outcome of a pediatric-inspired regimen used for adults aged 18–50 years with newly diagnosed acute lymphoblastic leukemia Daniel J. DeAngelo, Kristen E. Stevenson, Suzanne E. Dahlberg, Leukemia	2014	321
Postinduction Dexamethasone and Individualized Dosing of <i>Escherichia Coli</i> L-Asparaginase Each Improve Outcome of Children and Adolescents With Newly Diagnosed Acute Lymphoblastic Leukemia: Results From a Randomized Study—Dana-Farber Cancer Institute ALL Consortium Protocol 00-01 Lynda M. Vrooman, Kristen E. Stevenson, Jeffrey G. Supko, Journal of Clinical Oncology	2013	308
Long-term results of Dana-Farber Cancer Institute ALL Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1985–2000) Lewis B. Silverman, Kristen E. Stevenson, Jane E. O’Brien, Leukemia Hematological MalignancyOncologyPediatric HematologyHematologyPediatrics	2009	307
Intravenous pegylated asparaginase versus intramuscular native Escherichia coli l-asparaginase in newly diagnosed childhood acute lymphoblastic leukaemia (DFCI 05-001): a randomised, open-label phase 3 trial Andrew E. Place, Kristen E. Stevenson, Lynda M. Vrooman, The Lancet Oncology MedicineMicrobiologyOpen-label Phase 3Dfci 05-001	2015	234
Dietary Supplement Use During Chemotherapy and Survival Outcomes of Patients With Breast Cancer Enrolled in a Cooperative Group Clinical Trial (SWOG S0221) Christine B. Ambrosone, Gary Zirpoli, Alan D. Hutson, Journal of Clinical Oncology	2019	225
Pediatric Acute Lymphoblastic Leukemia, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology Patrick A. Brown, Hiroto Inaba, Colleen Annesley, Journal of the National Comprehensive Cancer Network Hematological MalignancyTranslational MedicineOncologyTransplantationPediatric Hematology	2020	204
Physical Activity Before, During, and After Chemotherapy for High-Risk Breast Cancer: Relationships With Survival Rikki Cannioto, Alan D. Hutson, Shruti Dighe, JNCI Journal of the National Cancer Institute	2020	179
Long-Term Results of CCG 5942: A Randomized Comparison of Chemotherapy With and Without Radiotherapy for Children With Hodgkin's Lymphoma—A Report From the Children's Oncology Group Suzanne L. Wolden, Lu Chen, Kara M. Kelly, Journal of Clinical Oncology	2012	163
t(11;22)(q23;q11.2) in acute myeloid leukemia of infant twins fuses <i>MLL</i> with hCDC <i>rel</i> , a cell division cycle gene in the genomic region of deletion in DiGeorge and velocardiofacial syndromes Maureen D. Megonigal, Eric Rappaport, Douglas H. Jones, Proceedings of the National Academy of Sciences	1998	160
Impact of hemochromatosis gene mutations on cardiac status in doxorubicin‐treated survivors of childhood high‐risk leukemia Steven E. Lipshultz, Stuart R. Lipsitz, Jeffery L. Kutok, Cancer	2013	158

Page 1